Bronchiectasis

The EMBARC Manual

  • James Chalmers
  • Eva Polverino
  • Stefano Aliberti

Table of contents

  1. Front Matter
    Pages i-viii
  2. Robert Wilson
    Pages 1-8
  3. Mario Silva, Gianluca Milanese, Nicola Sverzellati
    Pages 9-26
  4. Montserrat Vendrell, Dušanka Obradović, Roland Diel, Javier de Gracia
    Pages 27-37
  5. Diego J. Maselli, Marcos I. Restrepo
    Pages 39-49
  6. Rosario Menéndez, Oriol Sibila
    Pages 51-64
  7. Andrea Gramegna, Francesco Amati, James D. Chalmers, Stuart J. Elborn, Stefano Aliberti, Francesco Blasi
    Pages 65-76
  8. Tanya I. Coulter, Lisa Devlin, Damian Downey, J. Stuart Elborn, J. David M. Edgar
    Pages 77-100
  9. Anna Nogués Sabaté, José María Guilemany Toste
    Pages 101-106
  10. Miguel Angel Martínez-Garcia, Katerina Dimakou
    Pages 107-127
  11. Melissa J. McDonnell, Robert M. Rutherford
    Pages 129-145
  12. Tom M. Quinn, Adam T. Hill
    Pages 147-155
  13. Anthony De Soyza, Craig Winstanley
    Pages 157-180
  14. Michael R. Loebinger, Timothy Aksamit
    Pages 189-204
  15. Eva Polverino, Edmundo Rosales-Mayor, Antoni Torres
    Pages 205-222
  16. Michal Shteinberg, Chris Johnson, Charles Haworth
    Pages 223-239
  17. Pieter Christian Goeminne, Menno Van der Eerden
    Pages 241-256
  18. Judy Bradley, Katherine O’Neill, Jordi Vilaró, Maggie McIlwaine
    Pages 257-284
  19. Annemarie L. Lee, Anne E. Holland
    Pages 285-305

About this book

Introduction

This book presents state of the art knowledge and practice in the rapidly developing field of bronchiectasis not due to cystic fibrosis (referred to below simply as bronchiectasis). The focus is especially on diagnosis and existing and emerging therapies, but the book also covers a wide range of other key topics, from pathophysiology, histopathology, and immunology through to pulmonary rehabilitation, nursing care, and management in primary care and pediatric settings.

While bronchiectasis was formerly regarded as an “orphan” disease, international data reveal an increase in its prevalence in recent years. Accordingly, there has been renewed interest in the disease, resulting in more clinical research and the development of new treatments. The impact of bronchiectasis on healthcare systems is substantial and it has a clear attributable mortality. In covering all aspects of the disease, this book will be of interest to respiratory, internal medicine, and infectious disease fellows and specialists, final-year medical students, and nurses and physiotherapists. The authors are leading experts and chairs of the steering committee of EMBARC, the first truly international bronchiectasis network. 

Keywords

Airway disease Microbiology Inhaled antibiotics Chronic infection Recurrent respiratory infections Oral antibiotics Pulmonary rehabilitation Predisposing factors Airway clearance Nursing management

Editors and affiliations

  • James Chalmers
    • 1
  • Eva Polverino
    • 2
  • Stefano Aliberti
    • 3
  1. 1.College of MedicineUniversity of Dundee DundeeUnited Kingdom
  2. 2.Hospital Vall D’HebronVall D’Hebron Research Institute (VHIR) Respiratory Disease DepartmentBarcelonaSpain
  3. 3.Department of Pathophysiology and Transplantation, University of Milan Internal Medicine DepartmentRespiratory Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore PoliclinicoMilanItaly

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-319-61452-6
  • Copyright Information Springer International Publishing AG 2018
  • Publisher Name Springer, Cham
  • eBook Packages Medicine
  • Print ISBN 978-3-319-61451-9
  • Online ISBN 978-3-319-61452-6
  • Buy this book on publisher's site